Pediatr. praxi. 2016;17(4):220-223 | DOI: 10.36290/ped.2016.051

Pain relief options during the intramuscular benzathine penicillin G administration

PharmDr.Kateřina Ládová, Ph.D.1,2, PharmDr.Petra Thomson2, PharmDr.Milada Halačová, Ph.D.1, MUDr.Petr Jirák3
1 Oddělení klinické farmacie, Nemocnice Na Homolce, Praha
2 Katedra sociální a klinické farmacie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova v Praze
3 Oddělení otorinolaryngologie a chirurgie hlavy a krku, Nemocnice Na Homolce, Praha

Administration of the intramuscular injection of benzathine benzylpenicillin (benzathine PNC G) is associated with pain or discomfort,

which could lead to non‑adherence to the therapy. This risk may be even greater in children and adolescents, therefore,

it is desirable to minimize the pain, especially when medications containing benzathine PNC G alongside with other ingredients

relieving pain are not registered and commercially unavailable. This paper reviews evidence of published literature, describing

two alternatives which could be also employed in paediatric practice to alleviate the pain. Firstly, the procedure of mixing two

available medicinal products containing benzathine and procaine PNC G, secondly, the use of a lidocaine solution for reconstitution

of benzathine PNC G powder for injection. Reported evidence suggests both options are safe and does not lead to decrease

in PNC G serum concentrations. Finally, a case study is described demonstrating our clinical experience.

Keywords: benzathine penicillin G, lidocaine, pain, procaine penicillin G

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ládová K, Thomson P, Halačová M, Jirák P. Pain relief options during the intramuscular benzathine penicillin G administration. Pediatr. praxi. 2016;17(4):220-223. doi: 10.36290/ped.2016.051.
Download citation

References

  1. Brayfield A (ed.). Martindale: The complete drug reference. 38th edition. London: Pharmaceutical Press 2014: 4596 p.
  2. Hoza J, Jindrák V, Marešová V, et al. Konsensus používání antibiotik I: Penicilinová antibiotika [on line]. Společnost infekčního lékařství. [cit. 2016-05-05]. Dostupný z www: http://infekce.cz/Standardy/ATBkonsens1DP.pdf.
  3. Penicillin G Benzathine. [on line] AHFS - Drug Information May 2016 via MedicinesComplete. [cit. 2016-05-05]. Dostupný z www: http://www.medicinescomplete.com/
  4. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis. Circulation 2009; 119(11): 1541-1551. Go to original source...
  5. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55(10): e86-102. Go to original source... Go to PubMed...
  6. Drugs used in the treatment of streptococcal pharyngitis and prevention of rheumatic fever [on line]. Geneva: World Health Organisation, c1999. [cit. 2016-03-20]. Dostupný z www: http://apps.who.int/medicinedocs/pdf/s2252e/s2252e.pdf.
  7. Zákon MZ ČR č. 378/2007 Sb., o léčivech [on line]. c2016 [cit. 2016-03-20]. Dostupný z www: https://portal.gov.cz/app/zakony/zakonPar.jsp?idBiblio=65289&nr=378~2F2007&rpp=15#local-content
  8. Bell R. Review of the efficacy and safety of procaine benzylpenicillin in neonates. 17th Expert Committee on the Selection and Use of Essential Medicines [on line]. Geneva: World Health Organisation, c2009. [cit. 2016-01-25]. Dostupný z www: http://www.who.int/selection_medicines/committees/expert/17/application/Procainebenzylpenicillin.pdf.
  9. Bass JW. A review of the rationale and advantages of various mixtures of benzathine penicillin G. Pediatrics. 1996; 97(6 Pt 2): 960-963. Go to original source... Go to PubMed...
  10. Bycroft TC, O'Connor T, Hoff C, et al. When choosing injectable penicillin for the treatment of group A beta-hemolytic streptococcal pharyngitis, there is a less painful choice. Pediatr Emerg Care 2000; 16(6): 398-400. Go to original source... Go to PubMed...
  11. SPC Prokain Penicilin G 1,5 Biotika, revize textu 9/2013. [on line]. SÚKL. [cit. 2016-05-05]. Dostupný z www: http://www.sukl.cz/modules/medication/search.php.
  12. Treatment and prevention of streptococcal tonsillopharyngitis [on line]. UpToDate, Inc, c2016. [cit. 2016-05-05]. Dostupný z www: http://www.uptodate.com/contents/treatment-and-prevention-of-streptococcal-tonsillopharyngitis.
  13. SPC Retarpen 2,4 Mega IU, revize textu 5/2013. [on line]. SÚKL. [cit. 2016-05-05]. Dostupný z www: http://www.sukl.cz/modules/medication/search.php.
  14. Lexi-Comp: Internet database. Lexi-Comp Inc, 1978-2016. Updated periodically.
  15. Trissel LA. Handbook of Injectabel Drugs. 15th Ed. Bethesda: ASHP. 2009. 1681 p.
  16. Micromedex(R) Healthcare Series: Internet database. Greenwood Village, Colo: Truven Health Analytics Inc, c2016. Updated periodically.
  17. Eggleston ST, Lush LW. Understanding allergic reactions to local anesthetics. Ann Pharmacother 1996; 30(7-8): 851-857. Go to original source... Go to PubMed...
  18. Lidocaine (systemic) [on line]. UpToDate, Inc, c2016. [cit. 2016-05-05]. Dostupný z www: http://www.uptodate.com/contents/lidocaine-systemic-drug-information?source=search_result&search=lidocaine&selectedTitle=1%7E145.
  19. Amir J, Ginat S, Cohen YH, et al. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J 1998; 17(10): 890-893. Go to original source...
  20. Patel IH, Weinfeld RE, Konikoff J, et al. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents. Antimicrob Agents Chemother 1982; 21(6): 957-962. Go to original source... Go to PubMed...
  21. Schichor A, Bernstein B, Weinerman H, et al. Lidocaine as a diluent for ceftriaxone in the treatment of gonorrhea. Does it reduce the pain of the injection? Arch Pediatr Adolesc Med 1994; 148(1): 72-75. Go to original source...
  22. Morsy M, Mohamed MA, Abosedira MM. Lidocaine as a dilutant for benzathine penicillin G reduces injection pain in patients with rheumatic fever: a prospective, randomized, double-blinded crossover study. Australian J Basic Appl Sci 2012; 6: 236-240.
  23. Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health 2014; 50(2): 112-117. Go to original source...
  24. New Zealand Guidelines for Rheumatic Fever. Diagnosis, Management and Secondary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease [on line]. The Cardiac Society of Australia and New Zealand and Heart Foundation of New Zealand, c2014. [cit. 2016-03-20]. Dostupný z www: http://www.heartfoundation.org.nz/uploads/HF2227A_Rheumatic_Fever_Guideline_v3.pdf.
  25. New Zealand Guidelines for Rheumatic Fever. Group A Streptococcal Sore Throat Management Guideline [on line]. The Cardiac Society of Australia and New Zealand and Heart Foundation of New Zealand, c2014 [cit. 2016-03-20]. Dostupný z www: http://www.heartfoundation.org.nz/uploads/sore_throat_guideline_14_10_06_FINAL-revised.pdf.
  26. Wighley RD. The Primary Prevention of Rheumatic diseases. Camforth: Pantheon Publishing Group 1993: 370 p.
  27. Pattman R, Sankar N, Handy P, et al. Oxford Handbook of Genitourinary Medicine, HIV, and Sexual Health. New York: Oxford University Press 2010: 656 p. Go to original source...
  28. Rote Liste 2015. Frankfurt/Main: Herausgeber und Verlag 2015, 55. Aufgabe: 1984 s.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.